Literature DB >> 15544809

Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.

Honorata Czapinska1, Ronny Helland, Arne O Smalås, Jacek Otlewski.   

Abstract

The bovine chymotrypsin-bovine pancreatic trypsin inhibitor (BPTI) interaction belongs to extensively studied models of protein-protein recognition. The accommodation of the inhibitor P1 residue in the S1 binding site of the enzyme forms the hot spot of this interaction. Mutations introduced at the P1 position of BPTI result in a more than five orders of magnitude difference of the association constant values with the protease. To elucidate the structural aspects of the discrimination between different P1 residues, crystal structures of five bovine chymotrypsin-P1 BPTI variant complexes have been determined at pH 7.8 to a resolution below 2 A. The set includes polar (Thr), ionizable (Glu, His), medium-sized aliphatic (Met) and large aromatic (Trp) P1 residues and complements our earlier studies of the interaction of different P1 side-chains with the S1 pocket of chymotrypsin. The structures have been compared to the complexes of proteases with similar and dissimilar P1 preferences, including Streptomyces griseus proteases B and E, human neutrophil elastase, crab collagenase, bovine trypsin and human thrombin. The S1 sites of these enzymes share a common general shape of significant rigidity. Large and branched P1 residues adapt in their complexes similar conformations regardless of the polarity and size differences between their S1 pockets. Conversely, long and flexible residues such as P1 Met are present in the disordered form and display a conformational diversity despite similar inhibitory properties with respect to most enzymes studied. Thus, the S1 specificity profiles of the serine proteases appear to result from the precise complementarity of the P1-S1 interface and minor conformational adjustments occurring upon the inhibitor binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544809     DOI: 10.1016/j.jmb.2004.09.088

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Cleavage of peptide bonds bearing ionizable amino acids at P(1) by serine proteases with hydrophobic S(1) pocket.

Authors:  Mohammad A Qasim; Jikui Song; John L Markley; Michael Laskowski
Journal:  Biochem Biophys Res Commun       Date:  2010-08-26       Impact factor: 3.575

2.  Fluorine-induced polarity increases inhibitory activity of BPTI towards chymotrypsin.

Authors:  Jakob Leppkes; Nicole Dimos; Bernhard Loll; Thomas Hohmann; Michael Dyrks; Ariane Wieseke; Bettina G Keller; Beate Koksch
Journal:  RSC Chem Biol       Date:  2022-05-19

3.  Molecular insights into substrate specificity of prostate specific antigen through structural modeling.

Authors:  Pratap Singh; Aaron M LeBeau; Hans Lilja; Samuel R Denmeade; John T Isaacs
Journal:  Proteins       Date:  2009-12

4.  Structure of human prostasin, a target for the regulation of hypertension.

Authors:  Keith W Rickert; Paul Kelley; Noel J Byrne; Ronald E Diehl; Dawn L Hall; Allison M Montalvo; John C Reid; Jennifer M Shipman; Bradley W Thomas; Sanjeev K Munshi; Paul L Darke; Hua-Poo Su
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

5.  New Kunitz-Type HCRG Polypeptides from the Sea Anemone Heteractis crispa.

Authors:  Irina Gladkikh; Margarita Monastyrnaya; Elena Zelepuga; Oksana Sintsova; Valentin Tabakmakher; Oksana Gnedenko; Alexis Ivanov; Kuo-Feng Hua; Emma Kozlovskaya
Journal:  Mar Drugs       Date:  2015-09-24       Impact factor: 5.118

6.  Kunitz-Type Peptide HCRG21 from the Sea Anemone Heteractis crispa Is a Full Antagonist of the TRPV1 Receptor.

Authors:  Margarita Monastyrnaya; Steve Peigneur; Elena Zelepuga; Oksana Sintsova; Irina Gladkikh; Elena Leychenko; Marina Isaeva; Jan Tytgat; Emma Kozlovskaya
Journal:  Mar Drugs       Date:  2016-12-15       Impact factor: 5.118

7.  Molecular Characterization of Kunitz-Type Protease Inhibitors from Blister Beetles (Coleoptera, Meloidae).

Authors:  Emiliano Fratini; Marianna Nicoletta Rossi; Lucrezia Spagoni; Alessandra Riccieri; Emiliano Mancini; Fabio Polticelli; Marco Alberto Bologna; Paolo Mariottini; Manuela Cervelli
Journal:  Biomolecules       Date:  2022-07-15

8.  Atypical reactive center Kunitz-type inhibitor from the sea anemone Heteractis crispa.

Authors:  Irina Gladkikh; Margarita Monastyrnaya; Elena Leychenko; Elena Zelepuga; Victoria Chausova; Marina Isaeva; Stanislav Anastyuk; Yaroslav Andreev; Steve Peigneur; Jan Tytgat; Emma Kozlovkaya
Journal:  Mar Drugs       Date:  2012-07-19       Impact factor: 6.085

9.  Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI.

Authors:  Mi Li; Jaroslav Srp; Michael Mareš; Alexander Wlodawer; Alla Gustchina
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-07-29       Impact factor: 5.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.